Beyond TDP-43: hnRNPA1 and ANXA11 as contributors to TDP-43 proteinopathy in ALS-FTD

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia are neurodegenerative disorders characterized by a systemic collapse of cellular proteostasis, RNA processing, and long-range intracellular transport. Central to these pathologies is the misregulation of RNA-binding proteins (RBPs), particularly TDP-43, which forms a structural and biochemical nexus with other RNA-binding proteins. In this review we focus on two unexplored, yet critical, binding partners of TDP-43, hnRNPA1 and ANXA11. We highlight the role of hnRNPA1 as a coordinator of neuronal splicing networks as well as how its structural failure leads to the aberrant splicing of thousands of transcripts. We discuss how ANXA11 dysfunction contributes to axonal transport failure and nucleopathy, characterized by nuclear envelope instability and Lamin B2 mislocalization. We explore the pathological synergy between these proteins and TDP-43, which promotes heteromeric co-aggregation and the impairment of the autophagy-lysosome pathway. We examine how mutations in the low-complexity domains of these proteins disrupt liquid-liquid phase separation (LLPS), accelerating the transition from dynamic biomolecular condensates into toxic, irreversible amyloid-like aggregates. We highlight how aberrant nucleocytoplasmic trafficking acts as key contributing factor to this transition, and how advanced imaging tools, such as RNA aptamers, enable the mapping of these dynamics at the nanoscale level. Finally, we discuss emerging precision-based therapeutic strategies - including antisense oligonucleotides and small-molecule stabilizers targeting cryptic pockets - alongside the diagnostic utility of neurofilament light chain (NfL) biomarkers. By shifting from a gene-centric to a systems-level framework, this review provides a unified landscape of how nuclear RNA-processing defects and cytoplasmic-membrane trafficking failures act as interconnected, compartmentally diverse entry points into motor neuron degeneration.

Authors

Institutions

Publication Details

Journal
Frontiers in Molecular Biosciences
Published
2026-11-12
DOI
https://doi.org/10.3389/fmolb.2026.1999661
Primary Topic
Amyotrophic Lateral Sclerosis Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Beyond TDP-43: hnRNPA1 and ANXA11 as contributors to TDP-43 proteinopathy in ALS-FTD

Filippo Prischi, Salvatore Adinolfi, Eleonora Raccuia, Lorenzo Alfurno
Frontiers in Molecular Biosciences
Amyotrophic Lateral Sclerosis Research
article

Beyond TDP-43: hnRNPA1 and ANXA11 as contributors to TDP-43 proteinopathy in ALS-FTD

Filippo Prischi, Salvatore Adinolfi, Eleonora Raccuia, Lorenzo Alfurno
article en

Abstract

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia are neurodegenerative disorders characterized by a systemic collapse of cellular proteostasis, RNA processing, and long-range intracellular transport. Central to these pathologies is the misregulation of RNA-binding proteins (RBPs), particularly TDP-43, which forms a structural and biochemical nexus with other RNA-binding proteins. In this review we focus on two unexplored, yet critical, binding partners of TDP-43, hnRNPA1 and ANXA11. We highlight the role of hnRNPA1 as a coordinator of neuronal splicing networks as well as how its structural failure leads to the aberrant splicing of thousands of transcripts. We discuss how ANXA11 dysfunction contributes to axonal transport failure and nucleopathy, characterized by nuclear envelope instability and Lamin B2 mislocalization. We explore the pathological synergy between these proteins and TDP-43, which promotes heteromeric co-aggregation and the impairment of the autophagy-lysosome pathway. We examine how mutations in the low-complexity domains of these proteins disrupt liquid-liquid phase separation (LLPS), accelerating the transition from dynamic biomolecular condensates into toxic, irreversible amyloid-like aggregates. We highlight how aberrant nucleocytoplasmic trafficking acts as key contributing factor to this transition, and how advanced imaging tools, such as RNA aptamers, enable the mapping of these dynamics at the nanoscale level. Finally, we discuss emerging precision-based therapeutic strategies - including antisense oligonucleotides and small-molecule stabilizers targeting cryptic pockets - alongside the diagnostic utility of neurofilament light chain (NfL) biomarkers. By shifting from a gene-centric to a systems-level framework, this review provides a unified landscape of how nuclear RNA-processing defects and cytoplasmic-membrane trafficking failures act as interconnected, compartmentally diverse entry points into motor neuron degeneration.

Frontiers in Molecular BiosciencesVol. 13
King's College London (GB), University of Turin (IT)
Motor Neurone Disease Association, Università degli Studi di Torino, Biotechnology and Biological Sciences Research Council
Good health and well-being
Amyotrophic Lateral Sclerosis Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon